549.7000 -8.00 (-1.43%)
NSE Sep 11, 2026 15:31 PM
Volume: 394.9K
 

549.70
-1.43%
ICICI Securities Limited
Thyrocare’s Q2FY24 performance was in line with our expectations. Its revenue grew 9.7% YoY while the franchisee business grew faster at 20%. It reported an improvement in gross margins (+100bps YoY) due to a decline in the lowmargin Partnership business.
Number of FII/FPI investors increased from 137 to 144 in Jun 2026 qtr.
More from Thyrocare Technologies Ltd.
Recommended